Latest Insurance News

TruScreen Group Ltd reports a dip in FY25 sales but forecasts a robust rebound in FY26 driven by resumed programs and expansion in key emerging markets. Strategic partnerships and AI-enabled technology underpin its growth ambitions.

TruScreen Group Limited reported a 19% revenue decline in FY2025 due to delayed rollouts in key emerging markets but anticipates a strong rebound with FY2026 sales forecast to exceed NZ$2.8 million.

Turners Automotive Group has reported a record FY25 performance, with net profit after tax rising 17% to $38.6 million and dividends increasing 14% to 29.0 cents per share, showcasing resilience amid challenging economic conditions.

Turners Automotive Group has delivered a record FY25 profit and dividend, showcasing resilience amid economic challenges and positioning itself to exceed FY28 profit goals ahead of schedule.

Reef Casino Trust reported stable 2024 financial results with steady distributions, while confidential takeover proposals from two groups are under board review. Operational challenges include rising regulatory costs and inflationary pressures.

The Australian Wealth Advisors Group has deepened its Equity Partnership Scheme with strategic stakes in Oneledger and B2B Invest, setting up royalty revenue streams that align with its expansion in financial services.

The ACCC has decided not to oppose Insurance Australia Group’s proposed acquisition of RACQ Insurance, finding that competition in Queensland’s motor and home contents insurance markets remains robust despite the deal.

KPMG's latest actuarial report reveals a slight increase in asbestos-related disease liabilities for former James Hardie entities, driven by a notable rise in mesothelioma claims and evolving actuarial assumptions.

Tower Limited reported a robust half year profit for 2025, driven by improved claims performance and premium growth in its home insurance portfolio, despite ongoing challenges from Canterbury earthquake claims and competitive motor insurance pricing.

Lumos Diagnostics has secured Medicare reimbursement for its FebriDx test from a fifth contractor, covering more than 70% of US Medicare payments and advancing its commercial reach.

QBE Insurance Group has finalised the resale and buyback of its US$400 million perpetual capital notes, leading to their cancellation and delisting from the Singapore Exchange.

QBE Insurance Group has priced a AUD 600 million subordinated notes issuance, strengthening its capital base under APRA regulations with notes maturing in 2036.